1. Managing asthma in the COVID-19 pandemic and current recommendations from professional bodies: a review.
- Author
-
Ong, Kheng Yong, Tan, Tze Lee, Chan, Adrian Kwok Wai, Tan, Karen Li Leng, and Koh, Mariko Siyue
- Subjects
COVID-19 pandemic ,ASTHMA ,MEDICAL personnel ,VIRAL transmission ,COVID-19 - Abstract
To provide a summary of the management of asthma in the current COVID-19 pandemic by examining and comparing the recommendations from various professional bodies. Websites of known respiratory professional bodies were searched for COVID-19 guidance related to asthma. Subject matter experts were also consulted for useful resources. Resources that were targeted at healthcare professionals were included, while those targeting patients and the general public were excluded. There is currently little data to suggest that asthma protects from or increases the risk of COVID-19, nor is there any data to support strong recommendations for or against specific asthma treatments. Physicians should continue to manage asthma according to existing accepted asthma guidelines and recommendations. All prescribed medications, especially inhaled corticosteroids, should be continued, and, where indicated, oral corticosteroids and biologic therapies should still be used. Nebulizers and spirometry should be avoided where possible to reduce the risk of viral transmission. A detailed history should be taken to differentiate asthma exacerbations from COVID-19. Understanding similarities and differences among the recommendations of the various professional bodies will aid in medical decision-making in managing asthma in the COVID-19 pandemic. Health professionals should also consider the individual needs, preferences and values of their patients and the unique characteristics of their local healthcare systems. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF